The clinical phenotypes of the juvenile idiopathic inflammatory myopathies

Medicine (United States)

Volumn 92, Issue 1, 2013, Pages 25-41

  Shah, Mona ^a,c   Mamyrova, Gulnara ^a,d   Targoff, Ira N ^f   Huber, Adam M ^e   Malley, James D ^b   Rice, Madeline Murguia ^c   Miller, Frederick W ^a   Rider, Lisa G ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c Department of Epidemiology and Biostatistics ^*  (United States)

^d GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^e DALHOUSIE UNIVERSITY   (Canada)

^f UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CREATINE KINASE;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ARTHRALGIA; ARTICLE; CARPAL TUNNEL SYNDROME; CHILD; CLINICAL CLASSIFICATION; CLINICAL FEATURE; CONNECTIVE TISSUE DISEASE; CONNECTIVE TISSUE MYOPATHY; CONSTIPATION; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DEMOGRAPHY; DIARRHEA; DIGESTIVE SYSTEM ULCER; DISEASE REGISTRY; DISEASE SEVERITY; DRY EYE; DYSPHAGIA; DYSPHONIA; EDEMA; EOSINOPHILIA; ERYTHRODERMA; FAINTNESS; FATIGUE; FEMALE; FEVER; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEART PALPITATION; HELA CELL; HOSPITALIZATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOBLOTTING; INTERSTITIAL LUNG DISEASE; JOINT CONTRACTURE; JUVENILE DERMATOMYOSITIS; JUVENILE POLYMYOSITIS; LIPODYSTROPHY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MUSCLE ATROPHY; MUSCLE CRAMP; MUSCLE WEAKNESS; MYALGIA; MYOSITIS; OUTCOME ASSESSMENT; PAPULE; PHENOTYPE; PHOTOSENSITIVITY; PNEUMOTHORAX; PRESCHOOL CHILD; PRIORITY JOURNAL; RASH; RAYNAUD PHENOMENON; SCHOOL CHILD; SKIN ULCER; THORAX PAIN; VASCULAR DISEASE; WEIGHT REDUCTION;

AGE OF ONSET; AUTOANTIBODIES; CHI-SQUARE DISTRIBUTION; CHILD; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MYOSITIS; PHENOTYPE; PROGNOSIS; REGISTRIES; STATISTICS, NONPARAMETRIC;

EID: 84871920098     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0b013e31827f264d     Document Type: Article

References (58)

1. Arnett FC, Targoff IN, Mimori T, Goldstein R, Warner NB, Reveille JD.Interrelationship of major histocompatibility complex class II allelesand autoantibodies in four ethnic groups with various forms of myositis.Arthritis Rheum. 1996;39:1507-1518. (Pubitemid 26314984)
2. Barron KS, Silverman ED, Gonzales J, Reveille JD. Clinical, serologic,and immunogenetic studies in childhood-onset systemic lupuserythematosus. Arthritis Rheum. 1993;36:348-354. (Pubitemid 23090602)
3. Betteridge ZE, Gunawardena H, McHugh NJ. Novel autoantibodiesand clinical phenotypes in adult and juvenile myositis. Arthritis Res Ther.2011;13:209.
4. Bingham A, Mamyrova G, Rother KI, Oral E, Cochran E, Premkumar A,Kleiner D, James-Newton L, Targoff IN, Pandey JP, Carrick DM,Sebring N, O'Hanlon TP, Ruiz-Hidalgo M, Turner M, Gordon LB,Laborda J, Bauer SR, Blackshear PJ, Imundo L, Miller FW, Rider LG,Childhood Myositis Heterogeneity Study Group. Predictors of acquiredlipodystrophy in juvenile-onset dermatomyositis and a gradient ofseverity. Medicine (Baltimore). 2008;87:70-86.
5. Bohan A, Peter JB. Polymyositis and dermatomyositis. Parts 1 and 2.N Engl J Med. 1975;292:344Y347, 3403Y3407.
6. Christen-Zaech S, Seshadri R, Sundberg J, Paller AS, Pachman LM.Persistent association of nailfold capillaroscopy changes and skininvolvement over thirty-six months with duration of untreateddisease in patients with juvenile dermatomyositis. Arthritis Rheum.2008;58:571-576. (Pubitemid 351294893)
7. Crowe WE, Bove KE, Levinson JE, Hilton PK. Clinical andpathogenetic implications of histopathology in childhoodpolydermatomyositis. Arthritis Rheum. 1982;25:126-139. (Pubitemid 12170268)
8. Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis.Lancet. 2003;362:971-982. (Pubitemid 37159295)
9. Feldman BM, Rider LG, Reed AM, Pachman LM. Juveniledermatomyositis and other idiopathic inflammatory myopathiesof childhood. Lancet. 2008;2201Y2212
10. Fernandez C, Bardin N, Maues de Paula A, Salort-Campana E,Benyamine A, Franques J, Schleinitz N, Weiller PJ, Pouget J,Pellissier JF, Figarella-Branger D. Correlation of clinicoserologicand pathologic classifications of inflammatory myopathies: studyof 178 cases and guidelines for diagnosis. Medicine (Baltimore).2013;92:15-24.
11. Garton MJ, Isenberg DA. Clinical features of lupus myositis versusidiopathic myositis: a review of 30 cases. Br J Rheumatol.1997;36:1067- 1074.
12. Gourley M, Miller FW. Mechanisms of disease: environmental factorsin the pathogenesis of rheumatic disease. Nat Clin Pract Rheumatol.2007;3:172-180. (Pubitemid 46416266)
13. Gunawardena H, Betteridge ZE, McHugh NJ. Myositis-specificautoantibodies: their clinical and pathogenic significance in diseaseexpression. Rheumatology (Oxford). 2009;48:607-612.
14. Guseinova D, Consolaro A, Trail L, Ferrari C, Pistorio A, Ruperto N,Buoncompagni A, Pilkington C, Maillard S, Oliveira SK, Sztajnbok F,Cuttica R, Corona F, KatsicasMM, Russo R, Ferriani V, Burgos-Vargas R,Solis-Vallejo E, Bandeira M, Baca V, Saad-Magalhaes C, Silva CA,Barcellona R, Breda L, Cimaz R, Gallizzi R, Garozzo R, Martino S,Meini A, Stabile A, Martini A, Ravelli A. Comparison of clinicalfeatures and drug therapies among European and Latin Americanpatients with juvenile dermatomyositis. Clin Exp Rheumatol.2011;29:117- 124.
15. Harris-Love MO, Shrader JA, Koziol D, Pahlajani N, Jain M,Smith M, Cintas HL, McGarvey CL, James-Newton L, Pokrovnichka A,Moini B, Cabalar I, Lovell DJ, Wesley R, Plotz PH, Miller FW,Hicks JE, Rider LG. Distribution and severity of weakness amongpatients with polymyositis, dermatomyositis and juveniledermatomyositis. Rheumatology (Oxford). 2009;48:134-139.
16. Hashkes PJ, Wright BM, Lauer MS,Worley SE, Tang AS, Roettcher PA,Bowyer SL. Mortality outcomes in pediatric rheumatology in the US.Arthritis Rheum. 2010;62:599-608.
17. Hochberg MC, Feldman D, Stevens MB. Adult onset polymyositis/ dermatomyositis: an analysis of clinical and laboratory featuresand survival in 76 patients with a review of the literature.Semin Arthritis Rheum. 1986;15:168-178. (Pubitemid 16132225)
18. Huber AM, Lang B, LeBlanc CM, Birdi N, Bolaria RK, Malleson P,MacNeil I, Momy JA, Avery G, Feldman BM. Medium-and long-termfunctional outcomes in a multicenter cohort of children with juveniledermatomyositis. Arthritis Rheum. 2000;43:541-549. (Pubitemid 30394944)
19. Kao AH, Lacomis D, Lucas M, Fertig N, Oddis CV. Anti-signalrecognition particle autoantibody in patients with and patientswithout idiopathic inflammatory myopathy. Arthritis Rheum.2004;50:209-215. (Pubitemid 38084306)
20. Lorenzoni PJ, Scola RH, Kay CS, Prevedello PG, Espindola G,Werneck LC. Idiopathic inflammatory myopathies in childhood:a brief review of 27 cases. Pediatr Neurol. 2011;45:17-22.
21. Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas M, Plotz PH, MillerFW. A new approach to the classification of idiopathic inflammatorymyopathy: myositis-specific autoantibodies define useful homogeneouspatient groups. Medicine (Baltimore). 1991;70:360-374.
22. Lundberg IE, Forbess CJ. Mortality in idiopathic inflammatorymyopathies. Clin Exp Rheumatol. 2008;26(Suppl. 51):S109YS114.
23. Malley JD, Malley KG, Pajevic S. Statistical Learning for BiomedicalData. Cambridge: Cambridge University Press; 2011.
24. Mamyrova G, O'Hanlon TP, Monroe JB, Carrick DM, Malley JD,Adams S, Reed AM, Shamim EA, James-Newton L, Miller FW,Rider LG. Immunogenetic risk and protective factors for juveniledermatomyositis in Caucasians. Arthritis Rheum. 2006;54:3979-3987. (Pubitemid 44955902)
25. Martini G, Vittadello F, Kasapcopur O, Magni MS, Corona F,Duarte-Salazar C, Nemcova D, Len CA, Garay SM, Ullman S,Zulian F. Factors affecting survival in juvenile systemic sclerosis.Rheumatology (Oxford). 2009;48:119-122.
26. Mathiesen PR, Zak M, Herlin T, Nielsen SM. Clinical features andoutcome in a Danish cohort of juvenile dermatomyositis patients.Clin Exp Rheumatol. 2010;28:782-789.
27. McCann LJ, Juggins AD, Maillard SM, Wedderburn LR, Davidson JE,Murray KJ, Pilkington CA. The Juvenile Dermatomyositis NationalRegistry and Repository (UK and Ireland)Vclinical characteristics ofchildren recruited within the first 5 yr. Rheumatology (Oxford).2006;45:1255-1260. (Pubitemid 44542066)
28. Oddis CV, Rider LG, Reed AM, Ruperto N, Brunner HI, Koneru B,Feldman BM, Giannini EH, Miller FW. International consensusguidelines for trials of therapies in the idiopathic inflammatorymyopathies. Arthritis Rheum. 2005;52:2607-2615. (Pubitemid 41369088)
29. Pachman LM, Abbott K, Sinacore JM, Amoruso L, Dyer A,Lipton R, Ilowite N, Hom C, Cawkwell G, White A, Rivas-Chacon R,Kimura Y, Ray L, Ramsey-Goldman R. Duration of illness is animportant variable for untreated children with juvenile dermatomyositis.J Pediatr. 2006;148:247-253. (Pubitemid 43286768)
30. Pachman LM, Hayford JR, Chung A, Daugherty CA, Pallansch MA,Fink CW, Gewanter HL, Jerath R, Lang BA, Sinacore J, Szer IS, DyerAR, Hochberg MC. Juvenile dermatomyositis at diagnosis: clinicalcharacteristics of 79 children. J Rheumatol. 1998;25:1198-1204. (Pubitemid 28350898)
31. Pachman LM, Lipton R, Ramsey-Goldman R, Shamiyeh E, Abbott K,Mendez EP, Dyer A, Curdy DM, Vogler L, Reed A, Cawkwell G,Zemel L, Sandborg C, Rivas-Chacon R, Hom C, Ilowite N, Gedalia A,Gitlin J, Borzy M. History of infection before the onset of juveniledermatomyositis: results from the National Institute of Arthritis andMusculoskeletal and Skin Diseases Research Registry. Arthritis Rheum.2005;53:166-172. (Pubitemid 40530155)
32. Ponyi A, Constantin T, Balogh Z, Szalai Z, Borgulya G, Molnar K,Tefner I, Garami M, Fekete G, Danko K. Disease course, frequencyof relapses and survival of 73 patients with juvenile or adultdermatomyositis. Clin Exp Rheumatol. 2005;23:50-56. (Pubitemid 40424758)
33. Ramanan AV, Feldman BM. Clinical features and outcomes of juveniledermatomyositis and other childhood onset myositis syndromes.Rheum Dis Clin North Am. 2002;28:833-858.
34. Ravelli A, Trail L, Ferrari C, Ruperto N, Pistorio A, Pilkington C,Maillard S, Oliveira SK, Sztajnbok F, Cuttica R, Beltramelli M,Corona F, Katsicas MM, Russo R, Ferriani V, Burgos-Vargas R,Magni-Manzoni S, Solis-Valleoj E, Bandeira M, Zulian F, Baca V,Cortis E, Falcini F, Alessio M, Alpigiani MG, Gerloni V,Saad-Magalhaes C, Podda R, Silva CA, Lepore L, Felici E, Rossi F,Sala E, Martini A. Long-term outcome and prognostic factorsof juvenile dermatomyositis: a multinational, multicenter studyof 490 patients. Arthritis Care Res (Hoboken). 2010;62:63-72.
35. Rider LG, Lindsley C, Cassidy J. Juvenile dermatomyositis. In:Cassidy J, Petty R, Laxer R, Lindsley C, eds. Textbook of PediatricRheumatology. New York: Saunders Elsevier; 2011:375-413.
36. Rider LG, Miller FW. Classification and treatment of the juvenileidiopathic inflammatory myopathies. Rheum Dis Clin North Am.1997;23:619-655. (Pubitemid 27397123)
37. Rider LG, Miller FW. Deciphering the clinical presentations,pathogenesis, and treatment of the idiopathic inflammatory myopathies.JAMA. 2011;305:183-190.
38. Rider LG, Wu L, Mamyrova G, Targoff IN, Miller FW. Environmentalfactors preceding illness onset differ in phenotypes of the juvenileidiopathic inflammatory myopathies. Rheumatology (Oxford).2010;49:2381-2390.
39. Robinson AB, Reed AM. Clinical features, pathogenesis and treatmentof juvenile and adult dermatomyositis. Nat Rev Rheumatol.2011;7:664-675.
40. Rouster-Stevens KA, Pachman LM. Autoantibody to signal recognitionparticle in African American girls with juvenile polymyositis.J Rheumatol. 2008;35:927-929. (Pubitemid 351747139)
41. Sallum AM, Pivato FC, Doria-Filho U, Aikawa NE, Liphaus BL, MarieSK, Silva CA. Risk factors associated with calcinosis of juveniledermatomyositis. J Pediatr (Rio J). 2008;84:68-74. (Pubitemid 351287725)
42. Sanner H, Kirkhus E, Merckoll E, Tollisen A, Roisland M, Lie BA,Taraldsrud E, Gran JT, Flato B. Long-term muscular outcome andpredisposing and prognostic factors in juvenile dermatomyositis:a case-control study. Arthritis Care Res (Hoboken). 2010;62:1103-1111.
43. Sato JO, Sallum AM, Ferriani VP, Marini R, Sacchetti SB, Okuda EM,Carvalho JF, Pereira RM, Len CA, Terreri MT, Lotufo SA,Romanelli PR, Ramos VC, Hilario MO, Silva CA, Corrente JE,Saad-Magalhaes C. A Brazilian registry of juvenile dermatomyositis:onset features and classification of 189 cases. Clin Exp Rheumatol.2009;27:1031-1038.
44. Savioli C, Silva CA, Fabri GM, Kozu K, Campos LM, Bonfa E, SallumAM, de Siqueira JT. Gingival capillary changes and oral motorweakness in juvenile dermatomyositis. Rheumatology (Oxford).2010;49:1962-1970.
45. Serratrice G, Schiano A, Pellissier JF, Desnuelle C. Les expressionsanatomocliniques des polysyosites chez l'enfant: vingt-trois cas.Ann Pediatr (Paris). 1989;36:237-243. (Pubitemid 19106316)
46. Stringer E, Singh-Grewal D, Feldman BM. Predicting the course ofjuvenile dermatomyositis: significance of early clinical and laboratoryfeatures. Arthritis Rheum. 2008;58:3585-3592.
47. Sultan SM, Ioannou Y, Moss K, Isenberg DA. Outcome in patientswith idiopathic inflammatory myositis: morbidity and mortality.Rheumatology. 2002;41:22-26. (Pubitemid 34537916)
48. Symmons DP, Sills JA, Davis SM. The incidence of juveniledermatomyositis: results from a nation-wide study. Br J Rheumatol.1995;34:732-736.
49. Targoff IN. Autoantibodies to aminoacyl-transfer RNA synthetases forisoleucine and glycine. Two additional synthetases are antigenic inmyositis. J Immunol. 1990;144:1737-1743. (Pubitemid 20094004)
50. Targoff IN, Johnson AE, Miller FW. Antibody to signal recognitionparticle in polymyositis. Arthritis Rheum. 1990;33:1361-1370.
51. Targoff IN, Mamyrova G, Trieu EP, Perurena O, Koneru B, O'Hanlon TP,Miller FW, Rider LG. A novel autoantibody to a 155-kd protein isassociated with dermatomyositis. Arthritis Rheum. 2006;54:3682-3689. (Pubitemid 44737181)
52. Targoff IN, Trieu EP, Miller FW. Reaction of anti-OJ autoantibodies withcomponents of the multi-enzyme complex of aminoacyl-tRNAsynthetases in addition to isoleucyl-tRNA synthetase. J Clin Invest.1993;91:2556-2564. (Pubitemid 23182509)
53. Troyanov Y, Targoff IN, Tremblay JL, Goulet JR, Raymond Y, SenecalJL. Novel classification of idiopathic inflammatory myopathies basedon overlap syndrome features and autoantibodies: analysis of 100French Canadian patients. Medicine (Baltimore). 2005;84:231-249. (Pubitemid 41026298)
54. Uthman I, Vazquez-Abad D, Senecal JL. Distinctive features ofidiopathic inflammatory myopathies in French Canadians. SeminArthritis Rheum. 1996;26:447-458. (Pubitemid 26274718)
55. Vancsa A, Gergely L, Ponyi A, Lakos G, Nemeth J, Szodoray P, DankoK. Myositis-specific and myositis-associated antibodies in overlapmyositis in comparison to primary dermatopolymyositis: Relevance forclinical classification: retrospective study of 169 patients. Joint BoneSpine. 2010;77:125-130.
56. Van Rossum MA, Hiemstra I, Prieur AM, Rijkers GT, Kuis W. Juveniledermato/polymyositis: a retrospective analysis of 33 cases with specialfocus on initial CPK levels. Clin Exp Rheumatol. 1994;12:339-342. (Pubitemid 24165107)
57. Vegosen LJ, Weinberg CR, O'Hanlon TP, Targoff IN, Miller FW,Rider LG. Seasonal birth patterns in myositis subgroups suggest anetiologic role of early environmental exposures. Arthritis Rheum.2007;56:2719-2728. (Pubitemid 47237291)
58. Wedderburn LR, McHugh NJ, Chinoy H, Cooper RG, Salway F,Ollier WE, McCann LJ, Varsani H, Dunphy J, North J, Davidson JE.HLA class II haplotype and autoantibody associations in children withjuvenile dermatomyositis and juvenile dermatomyositis-sclerodermaoverlap. Rheumatology (Oxford). 2007;46:1786-1791. (Pubitemid 350176276)